Teladoc Health (TDOC)
(Delayed Data from NYSE)
$7.90 USD
+0.03 (0.38%)
Updated Sep 17, 2025 04:00 PM ET
After-Market: $7.92 +0.02 (0.25%) 7:28 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TDOC 7.90 +0.03(0.38%)
Will TDOC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TDOC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TDOC
Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
TDOC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?
Other News for TDOC
TDOC forms 20 Day Moving Average Support on September 16
Notable Wednesday Option Activity: TDOC, BHVN, MRVL
TDOC forms 20 Day Moving Average Support on September 15
TDOC forms 20 Day Moving Average Support on September 12
TDOC Crossed Above 20 Day Moving Average on September 11